Juvederm Volift 1x1 ml

JUVEDÉRM Volift Lidocaine is an advanced dermal filler based on cross-linked hyaluronic acid, developed using VYCROSS technology for the comprehensive correction of visible signs of aging. The product is designed to restore lost facial volume, enhance and shape the lips, and reduce deep wrinkles and nasolabial folds. Thanks to its flexible formulation, it provides natural-looking results and harmonious facial contouring. The addition of lidocaine improves patient comfort during the procedure. The aesthetic effects may last for up to 18 months.

Indications

• Loss of lip volume.

• Reduced volume in the cheeks and chin.

• Loss of facial contours and diminished definition of the facial oval.

• Deep wrinkles and nasolabial folds.

• Marionette lines and other signs of aging in the lower face.

Benefits

• Enhanced lip volume and improved lip contour.

• Restoration of volume in the cheeks and chin area.

• Improved facial contours and a more harmonious appearance.

• Smoothing of deep wrinkles and nasolabial folds.

• Natural-looking rejuvenation while preserving facial expressions.

• Long-lasting results for up to 18 months.

Active Ingredients

• Cross-linked Hyaluronic Acid (17.5 mg/ml) - intensely binds water, restores tissue volume, smooths wrinkles, and improves skin hydration and elasticity.

• Lidocaine (3 mg/ml) - a local anesthetic that enhances patient comfort during injection by reducing pain sensation.

Volume

1 × pre-filled syringe, 1 ml.

To order the full package containing 2 × 1 ml pre-filled syringes, please add the product to your cart twice.

Directions for Use

This product is intended exclusively for use by qualified physicians and cosmetologists trained in aesthetic medicine. It should be injected into the deep dermis or the lip mucosa using an appropriate injection technique suitable for the treatment area.

Contraindications

• Hypersensitivity to hyaluronic acid, lidocaine, or any component of the product.

• Pregnancy and breastfeeding.

• Active infections or inflammation at the intended injection site.

• Autoimmune diseases requiring individual medical assessment.

• Blood clotting disorders or the use of anticoagulant medication (following consultation with a healthcare professional).

• Predisposition to keloid scar formation.

• Active cancer or ongoing oncological treatment – the decision to perform the procedure should be made by the attending physician.